Order Article Reprints

Arslan S, Unal S, Gokce T, Atasoy BM, Gunduz O, Karademir B. Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures. Proceedings. 2018; 2(25):1579. https://doi.org/10.3390/proceedings2251579

Arslan, Sema, Semra Unal, Tilbe Gokce, Beste Melek Atasoy, Oguzhan Gunduz, and Betul Karademir. 2018. "Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures" Proceedings 2, no. 25: 1579. https://doi.org/10.3390/proceedings2251579

Arslan, S., Unal, S., Gokce, T., Atasoy, B. M., Gunduz, O., & Karademir, B. (2018). Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures. Proceedings, 2(25), 1579. https://doi.org/10.3390/proceedings2251579